AK

Ashutosh Kumar Pandey

Active Director Director DIN 11168650
DIN 11168650 First appointment Jun 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Ashutosh Kumar Pandey

Data last updated:

Ashutosh Kumar Pandey is a Director at Havit Homoeovet Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11168650
Primary Designation Director
Industry Pharma
First Appointment 24 Jun 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Jun 20252025Active

Board colleagues of Ashutosh Kumar Pandey

Directorship timeline

Open interactive timeline →
Havit Homoeovet Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ashutosh Kumar Pandey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashutosh Kumar Pandey

Ashutosh Kumar Pandey currently holds 1 directorship: Havit Homoeovet Pharmaceuticals Private Limited (Director, since 24 Jun 2025).

Ashutosh Kumar Pandey was first appointed on 24 Jun 2025 as Director at Havit Homoeovet Pharmaceuticals Private Limited.

The current boards of Ashutosh Kumar Pandey's companies include Hemant Kumar Gupta (Havit Homoeovet Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available